Release Date: 2024-06-10

The Effect of Magnesium on Neurological Diseases

Ismail Yapici (Author)

Release Date: 2024-06-10

There are various neurological diseases that negatively affect human life. Alzheimer’s disease, Parkinson’s disease, epilepsy, depression and migraine are among these diseases and they cause a wide variety of problems in people. It is known that the element Mg is involved in many metabolic events in the body. It regulates blood sugar level, blood pressure, [...]

Media Type
    Buy from

    Price may vary by retailers

    Work TypeBook Chapter
    Published inNeurological Diseases and Treatments in Terms of Biochemistry
    First Page37
    Last Page45
    DOIhttps://doi.org/10.69860/nobel.9786053359357.3
    Page Count9
    Copyright HolderNobel Tıp Kitabevleri
    Licensehttps://nobelpub.com/publish-with-us/copyright-and-licensing
    There are various neurological diseases that negatively affect human life. Alzheimer’s disease, Parkinson’s disease, epilepsy, depression and migraine are among these diseases and they cause a wide variety of problems in people. It is known that the element Mg is involved in many metabolic events in the body. It regulates blood sugar level, blood pressure, heart rhythm, muscle contraction and provides signal transmission. It serves as a cofactor in the structure of many enzymes . It has been reported in many studies that it also plays key roles in the brain and neurological organs. Mg has an antidepressant effect. It reduces depressive symptoms. It strengthens memory and learning by helping synaptic communication. It increases the effectiveness of antipsychotic drugs.

    Ismail Yapici (Author)
    Dr., PhD, Gümushane University
    https://orcid.org/0000-0001-9113-4845
    3PhD graduate, He studies enzymes and antioxidants in the field of biochemistry

    • Jahnen-Dechent, W.; Ketteler, M. (2012). Magnesium basics. CKJ Clin. Kidney J., 5 (Suppl. 1).

    • İzol, E., Çiçek, İ., Behçet, L., Kaya, E. & Tarhan, A. (2023). Trace Element Analysis of some Medicinal and Aromatic Plant Species by ICP-MS. Türk Doğa ve Fen Dergisi, 12 (1), 21-29.

    • Fiorentini, D., Cappadone, C., Farruggia, G., & Prata, C. (2021). Magnesium: biochemistry, nutrition, detection, and social impact of diseases linked to its deficiency. Nutrients, 13(4), 1136.

    • Mathew, A. A., & Panonnummal, R. (2021). ‘Magnesium’-the master cation-as a drug—possibilities and evidences. Biometals, 34(5), 955-986.

    • İzol, E., Kaya, E., &Karahan, D. (2021). “Investigation of Some Metals in Honey Samples Produced in Different Regions of Bingöl Province by ICP-MS. Mellifera 21(1): 1–17.

    • Izol, E. (2016). Determination of Heavy Metals and Seconder Metabolites of some Allium (Wild Garlic) Species by ICP-MS and LC-MS/ MS Investigation of Their Biological Activities. Dicle Üniversitesi, Fen Bil. Ens., Kimya ABD, Yüksek Lisans Tezi.

    • İzol, E., & İzol, İ. (2022). “Arı Ürünlerinin Spektroskopik Yöntemlerle Metal Konsantrasyonlarının Belirlenmesi ve Çevreye Etkileri”, In Tarımsal Üretimde, Tarımsal Kirliliğin Ayak İzi, ed. Kökten K., İnci Ş., Iksad International Publishing House, 1, 209–230.

    • Sun, Q., Weinger, J.G., Mao, F., Liu, G. (2016). Regulation of structural and functional synapse density by L-threonate through modulation of intraneuronal magnesium concentration. Neuropharmacology , 108, 426–439.

    • İzol, E., Çağlayan, C. (2023). “Heavy Metal Toxicity in Aquaculture”, In Progress in Aquaculture, ed. Kırıcı M., İzol E., Haspolat Y.K., Orient Publications, 15-24.

    • Seyama, T., Kamei, Y., Iriyama, T., Imada, S., Ichinose, M., Toshimitsu, M., Fujii, T., Asou, H. (2018). Pretreatment with magnesium sulfate attenuates white matter damage by preventing cell death of developing oligodendrocytes. J. Obstet. Gynaecol. Res., 44, 601–607.

    • Gulsoy, E., Tarhan, A., Izol, E., Dogru Cokran, B., Simsek, M. (2022). A research on chemical, mineral and fatty acid compositions of two almond cultivars grown as organic and conventional in South eastern Turkey. Grasas y Aceites, 73 (3), e477.

    • Thomas, A.P.; Diggle, T.A.; Denton, R.M., (1986). Sensitivity of pyruvate dehydrogenase phosphate phosphatase to magnesium ions. Similar effects of spermine and insulin. Biochem. J., 238, 83–91.

    • Caspi, R.; Billington, R.; Keseler, I.M.; Kothari, A.; Krummenacker, M.; Midford, P.E.; Ong, W.K.; Paley, S.; Subhraveti, P.; Karp, P.D., (2020). The MetaCyc database of metabolic pathways and enzymes—A 2019 update. Nucleic Acids Res., 48, D445–D453.

    • İzol, E. & İnik, O. (2022). Topraktaki Ağır Metallerin Güncel Analiz Yöntemleri. Avrupa Bilim ve Teknoloji Dergisi, 116-120.

    • Sartori, S.B.; Whittle, N.; Hetzenauer, A.; Singewald, N. (2012). Magnesium deficiency induces anxiety and HPA axis dysregulation: Modulation by therapeutic drug treatment. Neuropharmacology , 62, 304–312.

    • Winther, G.; Pyndt Jørgensen, B.M.; Elfving, B.; Nielsen, D.S.; Kihl, P.; Lund, S.; Sorensen, D.B.; Wegener, G. (2015). Dietary magnesium deficiency alters gut microbiota and leads to depressive-like behaviour. Acta Neuropsychiatr. , 27, 168–176.

    • Gröber, U. (2019). Magnesium and Drugs. Int. J. Mol. Sci., 20, 2094.

    • Fard, F.E.; Mirghafourvand, M.; Mohammad-Alizadeh Charandabi, S.; Farshbaf-Khalili, A.; Javadzadeh, Y.; Asgharian, H. (2017). Effects of zinc and magnesium supplements on postpartum depression and anxiety: A randomized controlled clinical trial. Women Health , 57, 1115–1128.

    • Botturi, A., Ciappolino, V., Delvecchio, G., Boscutti, A., Viscardi, B., & Brambilla, P. (2020). The role and the effect of magnesium in mental disorders: a systematic review. Nutrients, 12(6), 1661.

    • Lang UE, Beglinger C, Schweinfurth N, et al. (2015). Nutritional Aspects of Depression. Cell Physiol Biochem, 37: 1029-43.

    • De Baaij, JHF; Hoenderop, JGJ; (2015). Bindels, İnsanda RJM Magnezyum: Sağlık ve Hastalıklara Yönelik Etkiler. Fizyol. Rev., 95, 1–46.

    • Hansen, KB; Yi, F.; Perszyk, RE; Furukawa, H.; Wollmuth, LP; Gibb, AJ; Traynelis, SF (2018). NMDA reseptörlerinin yapısı, fonksiyonu ve allosterik modülasyonu. J. Gen. Physiol., 150 , 1081–1105.

    • Shin, H. J., Na, H. S., & Do, S. H. (2020). Magnesium and pain. Nutrients, 12(8), 2184.

    • Camardese, G.; De Risio, L.; Pizi, G.; Mattioli, B.; Buccelletti, F.; Serrani, R.; Leone, B.; Sgambato, A.; Bria, P.; Janiri, L. (2012). Plasma magnesium levels and treatment outcome in depressed patients. Nutr. Neurosci., 15, 78–84.

    • Xu ZP, Li L, Bao J, Wang ZH, Zeng J, Liu EJ, Li XG, Huang RX, Gao D, Li MZ, Zhang Y, Liu GP, Wang JZ (2014). Magnesium protects cognitive functions and synaptic plasticity in streptozotocin-induced sporadic Alzheimer’s model. PLoS ONE 9:1–11

    • Taubert, K. Magnesium in migraine. Results of a multicenter pilot study. Fortschr. Med. 1994, 112, 328–330.

    • Peikert, A.; Wilimzig, C.; Kohne-Volland, R. (1996). Prophylaxis of migraine with oral magnesium: Results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia , 16, 257–263.

    • Koseoglu, E.; Talaslioglu, A.; Gonul, A.S.; Kula, M. (2008). The effects of magnesium prophylaxis in migraine without aura. Magnes Res., 21, 101–108.

    • Yamanaka R, Shindo Y, Okak K (2019) Magnesium is a key player in neuronal maturation and neuropathology. Int J Mol Sci. https://doi.org/10.3390/ijms20143439

    Share This Chapter!